Promotion Contract With AstraZeneca Not To Be Continued In 2024

Apontis Pharma AG

31/07/2023 17:44

July 31 (Reuters) - Apontis Pharma Ag  APPHG.DE :
    * EQS-ADHOC: APONTIS PHARMA: CO-PROMOTION CONTRACT WITH
ASTRAZENECA NOT TO BE CONTINUED IN 2024
    * SAYS INFORMED BY ASTRAZENECA THAT CO-PROMOTION AGREEMENT
FOR
PRODUCT TRIXEO WILL BE TERMINATED IN 2023 AND NOT CONTINUED IN
2024
    * CO-PROMOTION ACTIVITIES BY APONTIS PHARMA WILL BE
DISCONTINUED
BY END OF OCTOBER 2023
    * EXPECTED TOTAL REVENUE FOR 2023 IS APPROXIMATELY EUR 3.0
MILLION
    * SAYS IMPACT ON EARNINGS IN FISCAL 2023 IS EXPECTED TO BE
MINOR

Source text for Eikon:  ID:nEQ1Wk9Xza 
Further company coverage:  APPHG.DE 

 ((Reuters.Briefs@thomsonreuters.com;))